Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 2/2011

01-06-2011 | Case Report

Renal epithelioid angiomyolipoma without obvious local progress in 10 years: a case report and literature review

Authors: J. Wen, H.-Z. Li, Z. G. Ji, Q. Z. Mao, B. B. Shi, W. G. Yan

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2011

Login to get access

Abstract

Epithelioid angiomyolipoma (eAMLoma) is an uncommon renal mesenchymal tumor with malignant potential. It is composed of tumor cells arranged in an epithelioid manner. Differential diagnosis from renal cell carcinoma is often challenging because of its epithelioid morphology. Herein is reported a case of eAMLoma, involving a 49-year-old man with eAMLoma. The patient had undergone radical nephrectomy via retroperitoneal laparoscope successfully. He had an uneventful postoperative recovery. The tumor was positive for Desmin, Hmb45, and Sma. We recommend surgical treatment and a follow-up regimen similar to that for renal carcinoma. There was no recurrence and metastases after 1-year follow-up.
Literature
1.
Yamamoto T, Ito K, Suzuki K et al (2002) Rapidly progressive malignant epithelioid angiomyolipoma of the kidney. J Urol 168:190–191PubMedCrossRef
2.
Wen MC, Jan YJ, Li MC et al (2010) Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression. Pathology. 42:300–302PubMedCrossRef
3.
Bharwani N, Christmas TJ, Jameson C et al (2009) Epithelioid angiomyolipoma: imaging appearances. Br J Radiol 82:249–252CrossRef
4.
Sato K, Ueda Y, Tachibana H et al (2008) Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis. Pathol Res Pract 204:771–777PubMedCrossRef
5.
Cho NH, Shim HS, Choi YD et al (2004) Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma. A clinicopathological and immunohistochemical study of 67 cases. Pathol Int 54:510–515PubMedCrossRef
6.
Eble JN, Amin MB, Young RH (1997) Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol 21:1123–1130PubMedCrossRef
7.
Gaston CL, Slavin J, Henderson M et al (2010) Epithelioid angiomyolipoma with skeletal and pulmonary metastasis on 8 year follow-up. Pathology. 42:591–594PubMedCrossRef
8.
9.
Faraji H, Nguyen BN, Mai KT (2009) Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance. Histopathology 55(5):525–534PubMedCrossRef
10.
Brimo F, Robinson B, Guo C et al (2010) Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol 34(5):715–722PubMed
Metadata
Title
Renal epithelioid angiomyolipoma without obvious local progress in 10 years: a case report and literature review
Authors
J. Wen
H.-Z. Li
Z. G. Ji
Q. Z. Mao
B. B. Shi
W. G. Yan
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0616-x

Other articles of this Issue 2/2011

Irish Journal of Medical Science (1971 -) 2/2011 Go to the issue

Original Article

The effects of the European Working Time Directive on surgical training: the basic surgical trainee’s perspective

Case Report

Pressure ulcers of the popliteal fossae caused by thromboembolic deterrent stockings (TEDS)

Original Article

Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population

Case Report

Sarcoidosis presenting with severe hypocalcaemia

Review Article

A practical guide to using the World Federation for Medical Education Standards. WFME 3: assessment of students

Case Report

Stercoral perforation in a 17-year old
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits